投研精选｜天士力(600535) 产品布局丰富业绩稳定增长

21经济网07-18

天士力 2023年实现营收86.74亿元，同比增长0.42%;实现归母净利润10.71亿元，同比增长505.34%;实现扣非归母净利润11.81亿元，同比增长60.11%。现代中药布局多款产品稳固中药龙头地位公司按照国际化创新标准和现代医学标准，以复方丹参滴丸带动了养血清脑颗粒(丸)、芪参益气滴丸、注射用益气复脉、注射用丹参多酚酸等系列领先品牌产品，构建了以心脑血管用药为主的现代中药大药体系。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2452314174?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-18 16:21","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2452314174","market":"sh","top_or_hot":-1,"title":"投研精选｜天士力(600535) 产品布局丰富 业绩稳定增长","media":"21经济网","content":"<div>\n<p>天士力 2023年实现营收86.74亿元，同比增长0.42%;实现归母净利润10.71亿元，同比增长505.34%;实现扣非归母净利润11.81亿元，同比增长60.11%。现代 中药 布局多款产品稳固中药龙头地位公司按照国际化创新标准和现代医学标准，以复方丹参滴丸带动了养血清脑颗粒(丸)、芪参益气滴丸、注射用益气复脉、注射用丹参多酚酸等系列领先品牌产品，构建了以心脑血管用药为主的现代中药大药体系。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071816302195d4416a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>投研精选｜天士力(600535) 产品布局丰富 业绩稳定增长</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n投研精选｜天士力(600535) 产品布局丰富 业绩稳定增长\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-18 16:21 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071816302195d4416a&s=b><strong>21经济网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>天士力 2023年实现营收86.74亿元，同比增长0.42%;实现归母净利润10.71亿元，同比增长505.34%;实现扣非归母净利润11.81亿元，同比增长60.11%。现代 中药 布局多款产品稳固中药龙头地位公司按照国际化创新标准和现代医学标准，以复方丹参滴丸带动了养血清脑颗粒(丸)、芪参益气滴丸、注射用益气复脉、注射用丹参多酚酸等系列领先品牌产品，构建了以心脑血管用药为主的现代中药大药体系。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071816302195d4416a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071816302195d4416a&s=b","article_id":"2452314174","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071816302195d4416a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2452314174","pubTimestamp":1721290914,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"天士力 2023年实现营收86.74亿元，同比增长0.42%;实现归母净利润10.71亿元，同比增长505.34%;实现扣非归母净利润11.81亿元，同比增长60.11%。在研产线丰富创新能力不断加强2023年，公司持续加大研发创新力度，加速数智中药研发进程，全年研发投入13.15亿元，同比增长29.49%。由于公司持续聚焦核心业务，创新实力逐渐加强，产品覆盖逐渐全面，不断强化内生增长驱动，维持“买入”评级。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600535":"天士力","BK0239":"医药制造","BK0012":"证金概念","BK0196":"行业龙头","BK0188":"融资融券","BK0028":"国家队","BK0183":"MSCI概念"},"translate_title":"Investment Research Selection | Tasly (600535) has rich product layout and steady growth in performance","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600535":1},"content_text":"天士力 2023年实现营收86.74亿元，同比增长0.42%;实现归母净利润10.71亿元，同比增长505.34%;实现扣非归母净利润11.81亿元，同比增长60.11%。现代 中药 布局多款产品稳固中药龙头地位公司按照国际化创新标准和现代医学标准，以复方丹参滴丸带动了养血清脑颗粒(丸)、芪参益气滴丸、注射用益气复脉、注射用丹参多酚酸等系列领先品牌产品，构建了以心脑血管用药为主的现代中药大药体系。此外，公司心脑血管在研管线覆盖高血脂症、抗血栓、脑卒中、脑卒中后遗症、心衰、冠心病等适应症，形成贯穿心脑血管疾病预防、治疗及康复各个环节、品类齐全的产品链，保持在心脑血管 创新药 领域的领先优势。2023年，公司创新中药研发与重点品种二次开发快速推进，管线中19款现代中药研发产品处于临床II、III期研究阶段。在研产线丰富创新能力不断加强2023年，公司持续加大研发创新力度，加速数智中药研发进程，全年研发投入13.15亿元，同比增长29.49%。公司研发管线高效推进，通过“四位一体”的研发模式拥有涵盖98款在研产品的研发管线，包含41款1类创新药，36款处于临床试验阶段，26款正在临床II、III期阶段：2款中药经典名方枇杷清肺饮、温经汤提交生产申请;9款创新中药处于临床III期研究阶段。盈利预测考虑到公司业务可能面临的集采降价风险，可能对公司经营产生影响，因此我们调整公司盈利预期。我们预计2024年-2026年公司营业收入为91.81亿元、96.24亿元、100.10亿元，归母净利润为11.34亿元、12.14亿元、12.84亿元，对应PE为20.20x、18.87x、17.84x。由于公司持续聚焦核心业务，创新实力逐渐加强，产品覆盖逐渐全面，不断强化内生增长驱动，维持“买入”评级。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2452314174"}

投研精选｜天士力(600535) 产品布局丰富 业绩稳定增长

精彩评论

投研精选｜天士力(600535) 产品布局丰富业绩稳定增长